Equipment for improving medicine absorption based on low-frequency resonance

The low-frequency resonance equipment regulates the cell sodium and potassium pump, which solves the problem of difficulty in drug absorption, realizes cell activation and repair, and improves the drug absorption effect and cell metabolism speed.

CN118903672APending Publication Date: 2024-11-08SHIBEIHAO MEDICAL TECHNOLOGY (FOSHAN) CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411055601.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-02
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

The prior art is difficult to absorb drugs when treating cell disorders, and the effects of magnetic therapy and thermal therapy are not obvious.

Method used

Using a low-frequency resonance device, including far-infrared module and resonance module, the cell sodium and potassium pump is regulated through far-infrared light and resonance vibration, to enhance the potential of the cell membrane sodium and potassium pump, enhance the drug absorption effect, and target the microelectroelectric release chip. Release micro currents to promote cell repair.

Benefits of technology

Effectively improve the mitochondrial membrane potential of cells, activate cells, enhance drug absorption effect, accelerate cell repair and regeneration, improve cell metabolism speed, and promote blood circulation and blood vessel clearance.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118903672A_ABST
    Figure CN118903672A_ABST
Patent Text Reader

Abstract

A device for improving medicine absorption based on low-frequency resonance comprises a physical therapy bin, a physical therapy area is arranged in the physical therapy bin, and a far infrared module irradiating a human body and a resonance module composed of a plurality of resonance chips are arranged in the physical therapy area of the physical therapy bin. A plurality of resonance chips of the resonance module are distributed in a cloud gathering manner to form a phase-controlled resonance array, the resonance module further comprises a micro-electric release chip and a processing module, and the micro-electric release module receives an instruction of the processing module to release micro-current according to the distribution of the phase-controlled resonance array. Under the combined action of the far infrared module and the resonance module, a cell sodium and potassium ion channel is regulated and controlled, cell membrane sodium and potassium pump potential change is achieved, cell mitochondrial membrane potential is improved, mitochondria is activated, human cells are more active, the cell metabolism speed is increased, and the drug absorption effect of the cells is enhanced.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the field of physical therapy, in particular to a device for improving drug absorption based on low-frequency resonance. Background Art

[0002] The human body is composed of cells, which are the basis of human organs and tissues. Cells are the basic structural and functional units of life, and the state of cells is the determining factor that affects and determines human health. When the organs and tissues of the human body are lesioned, the cells that constitute the basis of the lesions are disordered. Cell disorder is a warning from the cells to the human body, which is manifested externally as a sub-healthy state, and even local tissue damage, such as ulcers, inflammation, etc., and even worse, symptoms of organ decline. The main problem of cell disorder is the abnormality of the cell sodium-potassium pump. At the same time, the mitochondrial membrane potential plays an important role in maintaining the balance of substances inside and outside the mitochondria and maintaining the normal function of the mitochondria.

[0003] In the normal state, due to the unbalanced ion distribution on both sides of the cell membrane and the high permeability of the membrane to K+, there is a potential difference between the positive outside and the negative inside on both sides of the cell. In cell disorders, mitochondria are at a low potential level, which inhibits the activation and growth of cells and causes difficulties in cellular drug absorption. Therefore, the normal operation of the cell sodium-potassium pump is crucial to human health. In the existing technology, most of the treatment methods such as magnetic therapy, heat therapy, and negative oxygen ions are used to repair cells, but the effect is not obvious. Summary of the invention

[0004] In order to overcome the above-mentioned shortcomings of the prior art, the purpose of the present invention is to provide a device for improving drug absorption based on low-frequency resonance to solve the problems raised by the above-mentioned background technology.

[0005] The technical solution adopted by the present invention to solve its technical problems is: a device for improving drug absorption based on low-frequency resonance, including a physiotherapy chamber, wherein the physiotherapy chamber has a physiotherapy area, wherein the physiotherapy chamber is provided with a far-infrared module for irradiating the human body and a resonance module composed of several resonance chips in the physiotherapy area, wherein the several resonance chips of the resonance module are gathered and distributed to form a phased resonance array, and the resonance module also includes a micro-electric release chip and a processing module, wherein the micro-electric release module receives instructions from the processing module and releases micro-current according to the distribution of the phased resonance array.

[0006] As a further improvement of the present invention: the far-infrared module emits low-frequency far-infrared light through a far-infrared generator, wherein the far-infrared generator includes a low-frequency infrared chip.

[0007] As a further improvement of the present invention: the far infrared light intensity of the low-frequency infrared chip is 3.0-5.0 mW / cm 2 .

[0008] As a further improvement of the present invention: the resonance chip includes a resonance generator and a signal receiver, the signal receiver is used to receive bioelectric information emitted by the human body to the outside of the body, and the resonance generator is used to send working resonance information to the human body.

[0009] As a further improvement of the present invention: the resonance chip of the phased resonance array drives the resonance module to generate resonance through 40Hz vibration to provide whole-body vibration tactile stimulation to the human body; wherein the 40Hz vibration includes 40Hz sound vibration, 40Hz visible light or 40Hz tactile vibration.

[0010] As a further improvement of the present invention: the micro-electric release chip receives the bioelectric information emitted by the human body to the outside of the body according to the signal receiver of the resonance chip, and analyzes the bioelectric information through the processing module to release micro-electric stimulation to the human body.

[0011] As a further improvement of the present invention: the micro-electric release chip releases electric current to specific parts of the human body with a current value of less than 4 mA and a current frequency of 30-60 Hz according to the bioelectric information received by the phased resonance array.

[0012] As a further improvement of the present invention: the far infrared module includes the following treatment methods, and also includes:

[0013] Based on low-frequency infrared chip, the light intensity emitted to the patient's whole body is 3.0-5.0mW / cm 2 Far infrared light is used to obtain the patient's whole body imaging data in real time, and the data is pre-processed to obtain the abnormal parts of the patient's cells;

[0014] The phased resonant array composed of resonant chips resonates to provide 40Hz whole-body vibration tactile stimulation to the patient. During the tactile stimulation, the cell membrane sodium-potassium pump is converted from a resting potential to an action potential, thereby determining the reliability of the abnormal location of the patient's cells;

[0015] The processing module sends an irradiation instruction to the low-frequency infrared chip according to the data of the abnormal cell site of the patient, and controls the low-frequency infrared chip to enhance the light intensity of the abnormal cell site of the patient.

[0016] As a further improvement of the present invention: the resonance module includes the following treatment methods, further comprising:

[0017] Preset the threshold for the relative movement of the sodium-potassium pump and action potential at the resting potential;

[0018] The phased resonant array composed of resonant chips resonates to provide patients with 40Hz whole-body vibratory tactile stimulation, which converts the cell membrane sodium-potassium pump from resting potential to action potential during tactile stimulation;

[0019] The signal receiver of the resonance chip receives the bioelectric information transmitted by the patient, including the change of the potential of the cell membrane sodium-potassium pump, and analyzes the change of the potential of the cell membrane sodium-potassium pump of cells in various parts of the patient under the resonance state through the processing module;

[0020] If any resonance chip has cell obstruction and abnormal changes in the potential of the cell membrane sodium-potassium pump, the resonance effect of the resonance chip is enhanced to increase the changes in the potential of the cell membrane sodium-potassium pump, thereby enhancing the mitochondrial membrane potential.

[0021] As a further improvement of the present invention: the resonance module includes the following treatment methods, further comprising:

[0022] The micro-electric release chips are arranged according to the phased resonance array;

[0023] If any resonance chip has cell obstruction and the cell membrane sodium-potassium pump potential changes abnormally, the micro-electric release chip receives the instruction of the processing module, and the instruction causes the corresponding micro-electric release chip at the part with cell obstruction in the phased resonance array to release micro-electricity with a current value of less than 4mA and a current frequency of 30-60Hz, thereby increasing the cell membrane sodium-potassium pump potential change to enhance the mitochondrial membrane potential;

[0024] In the local micro-electric release chip of the micro-electric release chip, the instruction causes the local micro-electric release chip to release micro-electricity with a current value of less than 2 mA and a current frequency of 15-30 Hz.

[0025] Compared with the prior art, the present invention has the following beneficial effects:

[0026] 1. In the present invention, far-infrared rays with a frequency close to that of human cells are emitted through a far-infrared module to regulate the sodium-potassium ion channels of cells, realize the change of the potential of the sodium-potassium pump of the cell membrane, improve the mitochondrial membrane potential of cells and activate mitochondria, make human cells more active, enhance the drug absorption effect of cells, and have a repairing effect on cells, increase the cell metabolism rate, thereby accelerating cell repair and regeneration.

[0027] 2. In the present invention, the resonance generated by the low-frequency vibration of the resonance module provides whole-body vibration tactile stimulation to the patient, and transmits and penetrates from the outside to the inside, resonates with the cells in the body, regulates the sodium and potassium ion channels of the cells, realizes the change of the potential of the cell membrane sodium and potassium pump, and then promotes the activity of cells in the body, enhances the drug absorption effect of cells, increases the cell metabolism rate, and massages the human body surface, thereby promoting blood circulation and improving the effect of dredging blood vessels. BRIEF DESCRIPTION OF THE DRAWINGS

[0028] Figure 1 It is a structural schematic diagram of the present invention;

[0029] Figure 2 It is a structural schematic diagram of the resonance module of the present invention;

[0030] Figure 3 This is a schematic diagram of mitochondrial comparison in Experiment 1d of the present invention;

[0031] Figure 4 This is a schematic diagram of the structure of 3D mitochondrial comparison in the present invention's experiment;

[0032] Figure 5 This is a schematic diagram of the structure of mitochondria comparison in the 5d experiment of the present invention;

[0033] Figure 6 This is a schematic diagram of the structure for comparing the results of Experiment 1d of the present invention;

[0034] Figure 7 It is a structural schematic diagram of the comparison of the 3D results of the experiment of the present invention;

[0035] Figure 8 This is a schematic diagram of the structure for comparing the results of Experiment 5d of the present invention.

[0036] Numbers in the figure: 1, physical therapy area, 2, far infrared module, 3, resonance module, 31, resonance chip. DETAILED DESCRIPTION

[0037] In order to make the purpose, technical solution and advantages of the present invention clearer, the technical solution of the present invention will be clearly and completely described below in conjunction with the specific embodiments of the present invention and the corresponding drawings. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without making creative work are within the scope of protection of the present invention.

[0038] There are many reasons for mutations in human cells, such as air pollution and water pollution. Due to the pollution of the living environment, various toxins enter the human body and accumulate and precipitate in the body for a long time. Normal cells are eroded and poisoned, leading to cell mutations. The external manifestations are various pathological conditions. Organs with more toxins are more susceptible to diseases. For example, respiratory diseases, digestive system and other organs are often high-risk areas for diseases. When lesions occur in various organs and tissues of the human body, the cells that form the basis of the lesions are obstructed. Cell obstruction is a warning from the cells to the human body. The external manifestations are sub-healthy, and even local tissue damage may occur, such as ulcers, inflammation, etc., and even worse, symptoms of human organ decline. The main problem of cell obstruction is the abnormality of the cell sodium-potassium pump.

[0039] In the normal state, due to the unbalanced ion distribution on both sides of the cell membrane and the high permeability of the membrane to K+, there is a potential difference between the positive outside and the negative inside on both sides of the cell. In cell disorders, mitochondria are at a low potential level, which inhibits the activation and growth of cells and causes difficulties in cellular drug absorption. Therefore, the normal operation of the cell sodium-potassium pump is crucial to human health. In the prior art, most of the treatment methods such as magnetic therapy, heat therapy, and negative oxygen ions are used to repair cells, but the effect is not obvious.

[0040] The sodium-potassium pump on the cell membrane is an important transmembrane protein that plays a key role in maintaining the ion balance and membrane potential inside and outside the cell. The sodium-potassium pump can obtain energy by decomposing ATP, and use this energy to actively transport Na+ and K+. It can transport Na+ from inside the cell to outside the cell against the concentration gradient, and transport K+ from outside the cell into the cell, thereby changing the potential inside and outside the cell and maintaining the osmotic pressure of the intracellular and extracellular fluids.

[0041] Far infrared is a type of electromagnetic radiation with a long wavelength, located in the region of the electromagnetic spectrum between visible light and microwaves. The wavelength range of far infrared is usually between 5.6-1000μm. Its wavelength is longer than visible light, so it cannot be directly perceived by the human eye. Far infrared has certain biological effects on the human body. It can penetrate deeply into the skin, muscles and tissues, generate heat, improve local blood circulation, help relieve muscle fatigue, reduce muscle soreness, etc.

[0042] The present invention is further described in conjunction with the accompanying drawings and embodiments: a device for improving drug absorption based on low-frequency resonance, comprising a physiotherapy chamber 1, wherein the physiotherapy chamber 1 has a physiotherapy area, wherein the physiotherapy chamber 1 is provided with a far-infrared module 2 for irradiating the human body and a resonance module 3 composed of a plurality of resonance chips 31 in the physiotherapy area, wherein the plurality of resonance chips 31 of the resonance module 3 are distributed in a cloud to form a phased resonance array, wherein the resonance module 3 also comprises a micro-electric release chip and a processing module, wherein the micro-electric release module is distributed according to the phased resonance array and receives instructions from the processing module to release micro-current.

[0043] The present invention emits far infrared rays with a frequency close to that of human cells through the far infrared module 2, regulates the sodium-potassium ion channels of cells, realizes the change of the potential of the sodium-potassium pump of the cell membrane, improves the mitochondrial membrane potential of cells and activates mitochondria, makes human cells more active, becomes a drug absorption accelerator, has a repairing effect on cells, increases the cell metabolism rate, and thus accelerates cell repair and regeneration.

[0044] Specifically, the far infrared module 2 emits low-frequency far infrared light through a far infrared generator, wherein the far infrared generator includes a low-frequency infrared chip.

[0045] Specifically, the far-infrared light intensity of the low-frequency infrared chip is 3.0-5.0 mW / cm2 .

[0046] Specifically, the resonance chip 31 includes a resonance generator and a signal receiver. The signal receiver is used to receive bioelectric information emitted by the human body to the outside of the body, and the resonance generator is used to send working resonance information to the human body.

[0047] In one embodiment of the present invention, the far infrared module 2 includes the following treatment methods, and also includes:

[0048] Based on low-frequency infrared chip, the light intensity emitted to the patient's whole body is 3.0-5.0mW / cm 2 Far infrared light is used to obtain the patient's whole body imaging data in real time, and the data is pre-processed to obtain the abnormal parts of the patient's cells;

[0049] The phased resonant array composed of the resonant chip 31 resonates to provide the patient with a 40Hz whole-body vibration tactile stimulation, which converts the cell membrane sodium-potassium pump from a resting potential to an action potential during the tactile stimulation, thereby determining the reliability of the abnormal location of the patient's cells;

[0050] The processing module sends an irradiation instruction to the low-frequency infrared chip according to the data of the abnormal cell site of the patient, and controls the low-frequency infrared chip to enhance the light intensity of the abnormal cell site of the patient.

[0051] Far infrared rays are close to the vibration frequency of cell molecules in the human body. After penetrating into the human body, they will cause the resonance effect of human cell molecules and regulate the sodium and potassium ion channels of cells. The thermal effect of far infrared rays can affect the permeability of cell membranes and the activity of ion pumps, thereby affecting the difference in ion concentration inside and outside cells. Specifically, far infrared rays cause the bending of cell membranes and the expansion of ion channels, thereby affecting the transport function of sodium and potassium pumps, achieving changes in the potential of cell membrane sodium and potassium pumps, improving the cell mitochondrial membrane potential and activating mitochondria. Specifically, when the frequency of far infrared light is consistent with the movement frequency of water molecules between cells, molecules and atoms in the body, a resonance effect will occur. The energy generated by far infrared light can be absorbed by organisms and cause the temperature deep in the subcutaneous tissue to rise. The resulting thermal effect activates water molecules in cells in a high-energy state, accelerates the synthesis of biological enzymes needed by the human body, and activates biological molecules such as proteins, thereby enhancing the human immune system and the tissue regeneration ability of biological cells, and accelerating the supply of nutrients and enzymes. The interaction between far-infrared electromagnetic radiation and living cells can be formed by changing the cell membrane potential and changing mitochondrial metabolism, and when targeted repairing cells with cellular disorders, far-infrared rays restore mitochondrial function, making human cells more active and enhancing the effect of cell absorption of drugs.

[0052] In one embodiment of the present invention, the resonance chip 31 of the phased resonance array drives the resonance module 3 to generate resonance through 40 Hz vibration to provide whole-body vibration tactile stimulation to the human body; wherein the 40 Hz vibration includes 40 Hz sound vibration, 40 Hz visible light or 40 Hz tactile vibration.

[0053] In one embodiment of the present invention, the resonance module 3 includes the following treatment methods, and further includes:

[0054] Preset the threshold for the relative movement of the sodium-potassium pump and action potential at the resting potential;

[0055] The phased resonant array composed of the resonant chip 31 resonates to provide the patient with a 40 Hz whole-body vibratory tactile stimulation, which converts the cell membrane sodium-potassium pump from a resting potential to an action potential during the tactile stimulation;

[0056] The signal receiver of the resonance chip 31 receives the bioelectric information transmitted by the patient, which includes the change of the potential of the cell membrane sodium-potassium pump, and analyzes the change of the potential of the cell membrane sodium-potassium pump of cells in various parts of the patient under the resonance state through the processing module;

[0057] If any resonance chip 31 has cell obstruction and abnormal changes in the potential of the cell membrane sodium-potassium pump, the resonance effect of the resonance chip 31 is enhanced to increase the changes in the potential of the cell membrane sodium-potassium pump, thereby enhancing the mitochondrial membrane potential.

[0058] The present invention sets a plurality of resonance chips 31 to form a phased resonance array, which conducts and penetrates from the outside to the inside through resonance, massages the surface of the human body, resonates with the cells in the body, and converts the cell membrane sodium-potassium pump from the resting potential to the action potential during resonance stimulation, and the action potential is not limited to the stimulated part, but will quickly conduct to the surroundings to induce nerve impulses. When resonance stimulation generates an action potential, a large number of sodium ion channels on the cell membrane are opened, and the sodium current into the cell membrane exceeds the potassium current out of the cell membrane, so that the net transmembrane current is into the cell membrane, realizing a positive feedback effect, generating an action potential, and after the action potential is generated, since the adjacent cell membrane is still in a resting state, a potential difference will be generated between the excited part and the unexcited part, thereby generating a local current. When the human body is stimulated by external factors, the membrane potential increases, causing a large number of cell membrane-controlled sodium channels to open. A large influx of sodium ions causes the membrane potential to continue to rise, and then more sodium channels continue to open. The two form a positive feedback effect, causing the cell membrane's permeability to sodium ions to increase dramatically, far greater than the permeability to potassium ions, improving the cell mitochondrial membrane potential and activating mitochondria, thereby promoting cell activity and enhancing the cell's absorption of drugs.

[0059] In one embodiment of the present invention, the micro-electric release chip receives bioelectric information emitted by the human body to the outside of the body through the signal receiver of the resonance chip 31, and analyzes the bioelectric information through the processing module to release micro-electric stimulation to the human body.

[0060] Specifically, the micro-electric release chip releases electric current to a specific part of the human body with a current value of less than 4 mA and a current frequency of 30-60 Hz according to the bioelectric information received by the phased resonance array.

[0061] In one embodiment of the present invention, the resonance module 3 includes the following treatment methods, and further includes:

[0062] The micro-electric release chips are arranged according to the phased resonance array;

[0063] If any resonance chip 31 has cell obstruction and the cell membrane sodium-potassium pump potential changes abnormally, the micro-electric release chip receives the instruction of the processing module, and the instruction causes the corresponding micro-electric release chip at the part with cell obstruction in the phased resonance array to release micro-electricity with a current value of less than 4mA and a current frequency of 30-60Hz, thereby increasing the cell membrane sodium-potassium pump potential change to enhance the mitochondrial membrane potential;

[0064] In the local micro-electric release chip of the micro-electric release chip, the instruction causes the local micro-electric release chip to release micro-electricity with a current value of less than 2 mA and a current frequency of 15-30 Hz.

[0065] In the present invention, the difference in electric field between normal tissue cells and cells with cell disorders in the human body is utilized to apply low-frequency current to various parts of the human body with cell disorders in a targeted manner, and treatment is performed in a manner that the positive and negative charges inside and outside the cells reach a balanced state through an applied voltage. This treatment method generates bioelectric resonance, activates the cell activity of tissues surrounding the cell disorder, enhances local blood circulation and metabolic capacity, and enhances the effect of cell absorption of drugs.

[0066] 1. Mitochondrial membrane potential detection experiment

[0067] 1.1 Experimental materials and instruments

[0068] Table 1 Main equipment involved in the experiment

[0069]

[0070] Table 2 Main reagents involved in the experiment

[0071]

[0072] 1.2 Experimental methods

[0073] Experimental Grouping

[0074] ①: PC12 cells;

[0075] ②: PC12 cells + H2O2;

[0076] ③: PC12 cells + H2O2 + low-frequency infrared chip;

[0077] ④: PC12 cells + H2O2 + resonance chip;

[0078] ⑤: PC12 cells + H2O2 + physical therapy chamber, in which the physical therapy chamber contains a low-frequency infrared chip and a resonance chip;

[0079] Culture conditions:

[0080] PC12 cells: 89% RPMI 1640 medium + 10% FBS + 1% P / S

[0081] Cell culture and treatment

[0082] 1) PC12 cells were revived by rapid thawing at 37°C, 2 mL of complete medium was added, centrifuged at 1200 rpm for 3 min, and the supernatant was discarded;

[0083] 2) Then add 3 mL of the corresponding complete culture medium and culture at 37°C with 5% CO2;

[0084] 3) After 24 hours of thawing, observe the growth of the cells. When the cell density reaches more than 80%, they can be passaged.

[0085] 4) Pour out the original culture medium in the culture dish, rinse twice with PBS, add 0.25% trypsin to digest the cells, observe the cell digestion, remove the trypsin after the cells become round, add complete culture medium to blow the cells into a single cell suspension, and mix the cells evenly;

[0086] 5) The cells were divided into plates according to a certain ratio, the cell concentration was adjusted to 5×105 cells / mL, and inoculated into 3.5 cm culture dishes and cultured in a 37°C, 5% CO2 incubator;

[0087] 6) According to the above experimental groups, the H2O2 stock solution was diluted with complete culture medium to a final concentration of 500 μM, and the cells in the chip / instrument group were adhered to the chip / instrument and co-cultured;

[0088] 7) The cells were cultured in a 37° C., 5% CO 2 incubator, and the mitochondrial membrane potential was detected after culturing for 1 day, 3 days, and 5 days.

[0089] Mitochondrial membrane potential detection

[0090] 1) Take cells from each group, add 2 μM JC-1 probe, and incubate at 37°C in the dark for 30 min;

[0091] 2) After washing the cells three times with PBS, the nuclei were stained with Hochest and photographed under a fluorescence microscope.

[0092] 1.3 Experimental Results

[0093] The experimental results show:

[0094] 1d: Compared with the normal group, the mitochondrial membrane potential of cells decreased significantly after H2O2 treatment; compared with the H2O2 group, there was no significant change in the mitochondrial membrane potential of cells after culture in the low-frequency infrared chip, resonance chip, and therapy chamber.

[0095] 3d: Compared with the normal group, the mitochondrial membrane potential of cells decreased significantly after H2O2 treatment; compared with the H2O2 group, the mitochondrial membrane potential of cells increased significantly after co-culture with low-frequency infrared chip and resonance chip, which had a repair effect on the cells. The mitochondrial membrane potential of cells increased significantly after culture in the therapy chamber, which had a repair effect on the cells.

[0096] 5d: Compared with the normal group, the mitochondrial membrane potential of cells decreased significantly after H2O2 treatment; compared with the H2O2 group, the mitochondrial membrane potential of cells increased significantly after co-culture with low-frequency infrared chip and resonance chip, which had a repair effect on the cells. The mitochondrial membrane potential of cells increased significantly after culture in the therapy chamber, which had a repair effect on the cells.

[0097] (*Compared with the control group: *P<0.05, **P<0.01; #Compared with the H2O2 group: #P<0.05, ##P<0.01)

[0098] In summary, after reading the present invention document, ordinary technicians in this field can make various other corresponding transformation schemes based on the technical scheme and technical concept of the present invention without creative mental work, which all fall within the scope of protection of the present invention.

Claims

1. A device for improving drug absorption based on low-frequency resonance, comprising a physiotherapy chamber, wherein the physiotherapy chamber has a physiotherapy area, characterized in that: The physiotherapy chamber is provided with a far-infrared module for irradiating the human body and a resonance module composed of several resonance chips in the physiotherapy area. The several resonance chips of the resonance module are gathered and distributed to form a phased resonance array. The resonance module also includes a micro-electric release chip and a processing module. The micro-electric release module releases micro-current according to the distribution of the phased resonance array and the instruction of the processing module.

2. The device for improving drug absorption based on low-frequency resonance according to claim 1, characterized in that: The far infrared module emits low-frequency far infrared light through a far infrared generator, wherein the far infrared generator includes a low-frequency infrared chip.

3. The device for improving drug absorption based on low-frequency resonance according to claim 2, characterized in that: The far infrared light intensity of the low-frequency infrared chip is 3.0-5.0 mW / cm 2 .

4. The device for improving drug absorption based on low-frequency resonance according to claim 3, characterized in that: The resonance chip comprises a resonance generator and a signal receiver, wherein the signal receiver is used to receive bioelectric information emitted by the human body to the outside of the body, and the resonance generator is used to send working resonance information to the human body.

5. The device for improving drug absorption based on low-frequency resonance according to claim 4, characterized in that: The resonance chip of the phased resonance array drives the resonance module to generate resonance through 40 Hz vibration to provide whole-body vibration tactile stimulation to the human body; wherein the 40 Hz vibration includes 40 Hz sound vibration, 40 Hz visible light or 40 Hz tactile vibration.

6. The device for improving drug absorption based on low-frequency resonance according to claim 5, characterized in that: The micro-electric release chip receives the bioelectric information emitted by the human body to the outside of the body through the signal receiver of the resonance chip, and analyzes the bioelectric information through the processing module to release micro-electric stimulation to the human body.

7. The device for improving drug absorption based on low-frequency resonance according to claim 6, characterized in that: The micro-electric release chip releases electric current to specific parts of the human body at a current value of less than 4 mA and a current frequency of 30-60 Hz according to the bioelectric information received by the phased resonance array.

8. The device for improving drug absorption based on low-frequency resonance according to claim 7, characterized in that: The far infrared module includes the following treatment methods, and also includes: Based on low-frequency infrared chip, the light intensity emitted to the patient's whole body is 3.0-5.0mW / cm 2 Far infrared light is used to obtain the patient's whole body imaging data in real time, and the data is pre-processed to obtain the abnormal parts of the patient's cells; The phased resonant array composed of resonant chips resonates to provide 40Hz whole-body vibration tactile stimulation to the patient. During the tactile stimulation, the cell membrane sodium-potassium pump is converted from a resting potential to an action potential, thereby determining the reliability of the abnormal location of the patient's cells; The processing module sends an irradiation instruction to the low-frequency infrared chip according to the data of the abnormal cell site of the patient, and controls the low-frequency infrared chip to enhance the light intensity of the abnormal cell site of the patient.

9. The device for improving drug absorption based on low-frequency resonance according to claim 8, characterized in that: The resonance module includes the following treatment methods, and also includes: Preset the threshold for the relative movement of the sodium-potassium pump and action potential at the resting potential; The phased resonant array composed of resonant chips resonates to provide patients with 40Hz whole-body vibratory tactile stimulation, which converts the cell membrane sodium-potassium pump from resting potential to action potential during tactile stimulation; The signal receiver of the resonance chip receives the bioelectric information transmitted by the patient, including the change of the potential of the cell membrane sodium-potassium pump, and analyzes the change of the potential of the cell membrane sodium-potassium pump of cells in various parts of the patient under the resonance state through the processing module; If any resonance chip has cell obstruction and abnormal changes in the potential of the cell membrane sodium-potassium pump, the resonance effect of the resonance chip is enhanced to increase the changes in the potential of the cell membrane sodium-potassium pump, thereby enhancing the mitochondrial membrane potential.

10. The device for improving drug absorption based on low-frequency resonance according to claim 9, characterized in that: The resonance module includes the following treatment methods, and also includes: The micro-electric release chips are arranged according to the phased resonance array; If any resonance chip has cell obstruction and the cell membrane sodium-potassium pump potential changes abnormally, the micro-electric release chip receives the instruction of the processing module, and the instruction causes the corresponding micro-electric release chip at the part with cell obstruction in the phased resonance array to release micro-electricity with a current value of less than 4mA and a current frequency of 30-60Hz, thereby increasing the cell membrane sodium-potassium pump potential change to enhance the mitochondrial membrane potential; In the local micro-electric release chip of the micro-electric release chip, the instruction causes the local micro-electric release chip to release micro-electricity with a current value of less than 2 mA and a current frequency of 15-30 Hz.